• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫酸吲哚酚与 syndecan-1 及游离型 miR-126 在慢性肾脏病中的相关性研究

Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease.

机构信息

Nephrology Dialysis and Transplantation Department, Amiens University Hospital, 80054 Amiens, France.

Nephrology Section, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium.

出版信息

Int J Mol Sci. 2021 Sep 29;22(19):10549. doi: 10.3390/ijms221910549.

DOI:10.3390/ijms221910549
PMID:34638892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8508835/
Abstract

Chronic kidney disease (CKD) is a major cause of death worldwide and is associated with a high risk for cardiovascular and all-cause mortality. In CKD, endothelial dysfunction occurs and uremic toxins accumulate in the blood. miR-126 is a regulator of endothelial dysfunction and its blood level is decreased in CKD patients. In order to obtain a better understanding of the physiopathology of the disease, we correlated the levels of miR-126 with several markers of endothelial dysfunction, as well as the representative uremic toxins, in a large cohort of CKD patients at all stages of the disease. Using a univariate analysis, we found a correlation between eGFR and most markers of endothelial dysfunction markers evaluated in this study. An association of miR-126 with all the evaluated uremic toxins was also found, while uremic toxins were not associated with the internal control, specifically . The correlation between the expression of endothelial dysfunction biomarker Syndecan-1, free indoxyl sulfate, and total p-cresyl glucuronide on one side, and miR-126 on the other side was confirmed using multivariate analysis. As CKD is associated with reduced endothelial glycocalyx (eGC), our results justify further evaluation of the role of correlated parameters in the pathophysiology of CKD.

摘要

慢性肾脏病(CKD)是全球范围内主要的死亡原因之一,与心血管疾病和全因死亡率的高风险相关。在 CKD 中,内皮功能障碍发生,尿毒症毒素在血液中积累。miR-126 是内皮功能障碍的调节剂,其在 CKD 患者中的血液水平降低。为了更好地了解疾病的病理生理学,我们将 miR-126 水平与疾病各个阶段的大量 CKD 患者的几种内皮功能障碍标志物以及代表性尿毒症毒素进行了相关性分析。使用单变量分析,我们发现 eGFR 与本研究中评估的大多数内皮功能障碍标志物之间存在相关性。miR-126 与所有评估的尿毒症毒素也存在关联,而尿毒症毒素与内部对照物(具体为.)没有关联。使用多变量分析证实了内皮功能障碍生物标志物 Syndecan-1、游离吲哚硫酸和总对甲酚葡糖苷酸与 miR-126 之间的表达的相关性。由于 CKD 与内皮糖萼(eGC)减少相关,我们的结果证明了进一步评估相关参数在 CKD 病理生理学中的作用的合理性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4273/8508835/12612ce907af/ijms-22-10549-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4273/8508835/71b904af2a98/ijms-22-10549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4273/8508835/e9f7d779e124/ijms-22-10549-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4273/8508835/12612ce907af/ijms-22-10549-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4273/8508835/71b904af2a98/ijms-22-10549-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4273/8508835/e9f7d779e124/ijms-22-10549-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4273/8508835/12612ce907af/ijms-22-10549-g003.jpg

相似文献

1
Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease.硫酸吲哚酚与 syndecan-1 及游离型 miR-126 在慢性肾脏病中的相关性研究
Int J Mol Sci. 2021 Sep 29;22(19):10549. doi: 10.3390/ijms221910549.
2
Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.蛋白结合型尿毒症毒素:慢性肾脏病患者心血管事件的新罪魁祸首。
Toxins (Basel). 2014 Feb 20;6(2):665-78. doi: 10.3390/toxins6020665.
3
Endothelial glycocalyx damage in kidney disease correlates with uraemic toxins and endothelial dysfunction.肾脏疾病中的内皮糖萼损伤与尿毒症毒素和内皮功能障碍相关。
BMC Nephrol. 2021 Jan 10;22(1):21. doi: 10.1186/s12882-020-02219-4.
4
Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.对慢性肾脏病的影响以及 AST-120 的缓解作用。
Toxins (Basel). 2018 Sep 11;10(9):367. doi: 10.3390/toxins10090367.
5
The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease.尿毒症毒素诱导的炎症反应对慢性肾脏病心血管负担的影响。
Toxins (Basel). 2018 Sep 23;10(10):384. doi: 10.3390/toxins10100384.
6
Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.硫酸吲哚酚——一种将慢性肾病患者的止血系统紊乱与心血管疾病患病率联系起来的尿毒症毒素。
BMC Nephrol. 2017 Jan 25;18(1):35. doi: 10.1186/s12882-017-0457-1.
7
Indoxyl Sulfate Elevated Lnc-SLC15A1-1 Upregulating CXCL10/CXCL8 Expression in High-Glucose Endothelial Cells by Sponging MicroRNAs.硫酸吲哚酚通过海绵吸附 microRNAs 上调高糖环境下内皮细胞中长链非编码 RNA-SLC15A1-1 表达,进而上调 CXCL10/CXCL8 的表达。
Toxins (Basel). 2021 Dec 7;13(12):873. doi: 10.3390/toxins13120873.
8
Indoxyl Sulfate, a Uremic Endotheliotoxin.硫酸吲哚酚,一种尿毒症内皮毒素。
Toxins (Basel). 2020 Apr 5;12(4):229. doi: 10.3390/toxins12040229.
9
Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.蛋白结合型尿毒症毒素、炎症和氧化应激:3-4 期慢性肾脏病的横断面研究。
Arch Med Res. 2014 May;45(4):309-17. doi: 10.1016/j.arcmed.2014.04.002. Epub 2014 Apr 18.
10
Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.益生元(果寡糖)对慢性肾脏病患者尿毒症毒素的影响:一项随机对照试验。
Nephrol Dial Transplant. 2019 Nov 1;34(11):1876-1884. doi: 10.1093/ndt/gfy171.

引用本文的文献

1
Impact of Micro-RNAs as biomarkers for end-stage renal disease related to hypertension and diabetes.微小RNA作为高血压和糖尿病相关终末期肾病生物标志物的影响
Sci Rep. 2025 Aug 24;15(1):31101. doi: 10.1038/s41598-025-16013-5.
2
Uremic toxins levels are associated with miR-223 in chronic kidney disease-associated anemia.在慢性肾脏病相关性贫血中,尿毒症毒素水平与miR-223相关。
Noncoding RNA Res. 2025 May 2;13:121-130. doi: 10.1016/j.ncrna.2025.04.009. eCollection 2025 Aug.
3
Evaluation of reference genes for qPCR in human liver and kidney tissue from individuals with obesity.

本文引用的文献

1
Novel predictive biomarkers for acute injury superimposed on chronic kidney disease.用于慢性肾脏病叠加急性损伤的新型预测生物标志物。
Nefrologia (Engl Ed). 2021 Mar-Apr;41(2):165-173. doi: 10.1016/j.nefroe.2021.05.001.
2
Non-Coding RNAs in Kidney Diseases: The Long and Short of Them.非编码 RNA 在肾脏疾病中的作用:长链非编码 RNA 和短链非编码 RNA。
Int J Mol Sci. 2021 Jun 4;22(11):6077. doi: 10.3390/ijms22116077.
3
miR-126-3p is essential for CXCL12-induced angiogenesis.微小RNA-126-3p对于趋化因子CXCL12诱导的血管生成至关重要。
肥胖个体人肝脏和肾脏组织中qPCR内参基因的评估。
Sci Rep. 2025 Feb 13;15(1):5347. doi: 10.1038/s41598-025-87911-x.
4
Current Understanding of Cardiovascular Calcification in Patients with Chronic Kidney Disease.慢性肾脏病患者心血管钙化的现有认识。
Int J Mol Sci. 2024 Sep 23;25(18):10225. doi: 10.3390/ijms251810225.
5
Analysis of the microecological mechanism of diabetic kidney disease based on the theory of "gut-kidney axis": A systematic review.基于“肠-肾轴”理论的糖尿病肾病微生态机制分析:一项系统评价
Open Life Sci. 2024 Aug 6;19(1):20220909. doi: 10.1515/biol-2022-0909. eCollection 2024.
6
Innovative Treatments to Counteract Endothelial Dysfunction in Chronic Kidney Disease Patients.对抗慢性肾脏病患者内皮功能障碍的创新疗法。
Biomedicines. 2024 May 14;12(5):1085. doi: 10.3390/biomedicines12051085.
7
Advances in the study of miRNAs in chronic kidney disease with cardiovascular complications.伴有心血管并发症的慢性肾脏病中微小RNA的研究进展
Front Physiol. 2023 Nov 23;14:1283597. doi: 10.3389/fphys.2023.1283597. eCollection 2023.
8
Acute Vascular Response to Hemodialysis as Measured by Serum Syndecan-1 and Endothelin-1 Levels as Well as Vascular Stiffness.通过血清Syndecan-1和内皮素-1水平以及血管僵硬度测量的血液透析急性血管反应
J Clin Med. 2023 Nov 29;12(23):7384. doi: 10.3390/jcm12237384.
9
Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure.尿毒症毒素对慢性肾衰竭患者结肠癌发展和进展的可能影响。
Genes (Basel). 2023 Jun 13;14(6):1257. doi: 10.3390/genes14061257.
10
Uremic Toxin Indoxyl Sulfate Promotes Macrophage-Associated Low-Grade Inflammation and Epithelial Cell Senescence.尿毒症毒素吲哚硫酸酯促进巨噬细胞相关的低度炎症和上皮细胞衰老。
Int J Mol Sci. 2023 Apr 28;24(9):8031. doi: 10.3390/ijms24098031.
J Cell Mol Med. 2021 Jul;25(13):6032-6045. doi: 10.1111/jcmm.16460. Epub 2021 Jun 12.
4
Phosphate, Microbiota and CKD.磷酸盐、微生物群与慢性肾脏病。
Nutrients. 2021 Apr 13;13(4):1273. doi: 10.3390/nu13041273.
5
Free p-cresyl sulfate shows the highest association with cardiovascular outcome in chronic kidney disease.游离对甲酚硫酸盐与慢性肾脏病患者心血管结局的相关性最高。
Nephrol Dial Transplant. 2021 May 27;36(6):998-1005. doi: 10.1093/ndt/gfab004.
6
Endothelial glycocalyx damage in kidney disease correlates with uraemic toxins and endothelial dysfunction.肾脏疾病中的内皮糖萼损伤与尿毒症毒素和内皮功能障碍相关。
BMC Nephrol. 2021 Jan 10;22(1):21. doi: 10.1186/s12882-020-02219-4.
7
Circulating argonaute-bound microRNA-126 reports vascular dysfunction and treatment response in acute and chronic kidney disease.循环中与AGO蛋白结合的微小RNA-126可反映急慢性肾病中的血管功能障碍及治疗反应。
iScience. 2020 Dec 13;24(1):101937. doi: 10.1016/j.isci.2020.101937. eCollection 2021 Jan 22.
8
MicroRNA-451 as an Early Predictor of Chronic Kidney Disease in Diabetic Nephropathy.微小RNA-451作为糖尿病肾病中慢性肾脏病的早期预测指标
Int J Nephrol. 2020 Aug 14;2020:8075376. doi: 10.1155/2020/8075376. eCollection 2020.
9
Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update.慢性肾脏病中的内皮功能障碍:从生物学机制到临床结局——2020年更新
J Clin Med. 2020 Jul 23;9(8):2359. doi: 10.3390/jcm9082359.
10
The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases.基质金属蛋白酶-7 在肾脏疾病中的多面性。
Biomolecules. 2020 Jun 25;10(6):960. doi: 10.3390/biom10060960.